Review: taking Pradaxa and Vitamin c together


Summary

Drug interactions are reported among people who take Pradaxa and Vitamin c together. This review analyzes the effectiveness and drug interactions between Pradaxa and Vitamin c. It is created by eHealthMe based on reports of 93 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Pradaxa and Vitamin c >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Pradaxa

Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. (latest outcomes from Pradaxa 38,203 users)

Vitamin C

Vitamin c has active ingredients of l-ascorbic acid. It is often used in vitamin supplementation. (latest outcomes from Vitamin c 6,306 users)

On Aug, 26, 2016

93 people who take Pradaxa, Vitamin C are studied.


Number of reports submitted per year:

Pradaxa and Vitamin c drug interactions.

Drug effectiveness over time:

Pradaxa:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Vitamin C:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Pradaxa:
  • female: 100.0% - (1 of 1 people)
  • male: 50.0% - (1 of 2 people)
Vitamin C:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Pradaxa:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 50.0% - (1 of 2 people)
Vitamin C:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • gastrointestinal haemorrhage
  • fall
  • haemorrhage
  • facial bones fracture
  • subdural haematoma
  • blood glucose increased
  • dyspepsia
  • eye haemorrhage
  • headache
  • pneumonia
1 - 6 months:
  • gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • anaemia
  • coagulopathy
  • cardiac failure congestive
  • epistaxis
  • haematochezia
  • haemorrhage
  • rectal haemorrhage
  • renal failure acute
6 - 12 months:
  • gastrointestinal haemorrhage
  • anaemia
  • coagulopathy
  • lower gastrointestinal haemorrhage
  • cerebral haemorrhage
  • cerebrovascular accident
  • epistaxis
  • haemoptysis
  • iron deficiency anaemia
  • abdominal discomfort
1 - 2 years:
  • coagulopathy
  • gastrointestinal haemorrhage
  • lower gastrointestinal haemorrhage
  • retinopathy diabetic
  • abdominal pain
  • acute myocardial infarction
  • acute respiratory failure
  • anaemia
  • atrial fibrillation
  • cardiac failure
2 - 5 years:
  • anaemia
  • confusional state
  • deep vein thrombosis
  • depression
  • dyspnoea
  • gastrointestinal haemorrhage
  • hepatic pain
  • mental disorder
  • oedema peripheral
  • pruritus generalised
not specified:
  • gastrointestinal haemorrhage
  • anaemia
  • haemorrhagic anaemia
  • coagulopathy
  • haemorrhage
  • arthralgia
  • lower gastrointestinal haemorrhage
  • fall
  • pain in extremity
  • cardiac failure congestive

Most common drug interactions by gender *:

female:
  • gastrointestinal haemorrhage
  • anaemia
  • coagulopathy
  • haemorrhagic anaemia
  • arthralgia
  • lower gastrointestinal haemorrhage
  • epistaxis
  • nausea
  • renal failure acute
  • upper gastrointestinal haemorrhage
male:
  • gastrointestinal haemorrhage
  • haemorrhage
  • haemorrhagic anaemia
  • fall
  • anaemia
  • cardiac failure congestive
  • cerebrovascular accident
  • lower gastrointestinal haemorrhage
  • facial bones fracture
  • subdural haematoma

Most common drug interactions by age *:

30-39:
  • cholecystitis chronic
  • cholelithiasis
  • eye disorder
  • gallbladder disorder
  • haemorrhage
  • mental disorder
50-59:
  • diarrhoea
  • abdominal pain lower
  • arthralgia
  • flatulence
  • pain in extremity
  • anxiety
  • asthenia
  • cough
  • dyspnoea
  • epistaxis
60+:
  • gastrointestinal haemorrhage
  • coagulopathy
  • anaemia
  • haemorrhagic anaemia
  • haemorrhage
  • cardiac failure congestive
  • cerebrovascular accident
  • fall
  • upper gastrointestinal haemorrhage
  • epistaxis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Pradaxa and Vitamin c?

Can you answer these questions?

More questions for: Pradaxa, Vitamin c

You may be interested in these reviews

More reviews for: Pradaxa, Vitamin c

On eHealthMe, Pradaxa (dabigatran etexilate mesylate) is often used to treat atrial fibrillation/flutter. Vitamin c (l-ascorbic acid) is often used to treat vitamin supplementation. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.